Press Release Perion Continues to Deliver Strong Results with 17% Year-Over-Year Increase in Revenue and 29% Growth in Adjusted EBITDA 1 November 2023
Press Release Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap 1 November 2023
Press Release Extreme Networks Reports First Quarter Fiscal Year 2024 Financial Results 1 November 2023
Press Release ​​California Teens to Have Equitable Access to Mobile Mental Health Support 1 November 2023
Press Release EVgo’s Prefabricated Charging Infrastructure Deployment Model Expected to Cut Installation Timelines by 50% on Average 1 November 2023
Press Release Bausch + Lomb Announces Third-Quarter 2023 Results and Raises Full-Year 2023 Guidance 1 November 2023
